IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.416
EU - Europa 6.628
AS - Asia 6.400
SA - Sud America 809
AF - Africa 97
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 13
Totale 23.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.215
SG - Singapore 2.582
CN - Cina 1.760
RU - Federazione Russa 1.379
UA - Ucraina 914
IE - Irlanda 888
SE - Svezia 781
IT - Italia 722
BR - Brasile 673
TR - Turchia 645
GB - Regno Unito 624
VN - Vietnam 581
DE - Germania 424
FR - Francia 398
IN - India 285
FI - Finlandia 213
HK - Hong Kong 122
CA - Canada 119
BD - Bangladesh 85
AR - Argentina 59
MX - Messico 59
PL - Polonia 57
JP - Giappone 50
ES - Italia 42
BE - Belgio 40
IQ - Iraq 39
NL - Olanda 36
ZA - Sudafrica 34
SA - Arabia Saudita 33
EC - Ecuador 28
KR - Corea 27
TW - Taiwan 25
AT - Austria 23
ID - Indonesia 22
AU - Australia 20
JO - Giordania 17
PK - Pakistan 15
CZ - Repubblica Ceca 14
KE - Kenya 14
UZ - Uzbekistan 14
VE - Venezuela 13
GR - Grecia 12
IL - Israele 12
LT - Lituania 12
EU - Europa 11
IR - Iran 11
EG - Egitto 10
RO - Romania 10
CO - Colombia 9
PY - Paraguay 9
TN - Tunisia 9
MA - Marocco 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
MY - Malesia 7
JM - Giamaica 6
NP - Nepal 6
BO - Bolivia 5
CH - Svizzera 5
CL - Cile 5
DZ - Algeria 5
LB - Libano 5
OM - Oman 5
PS - Palestinian Territory 5
TH - Thailandia 5
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
KZ - Kazakistan 4
NO - Norvegia 4
PE - Perù 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
AO - Angola 2
CI - Costa d'Avorio 2
CU - Cuba 2
HU - Ungheria 2
LK - Sri Lanka 2
LY - Libia 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
Totale 23.363
Salva come PNG Salva come JPEG
Città #
Singapore 1.915
San Jose 1.103
Chandler 1.099
Jacksonville 1.041
Dublin 871
Ashburn 611
Princeton 437
Beijing 423
Southend 385
Dallas 344
Izmir 327
Nanjing 291
Dearborn 247
Los Angeles 228
Wilmington 222
Santa Clara 213
Ho Chi Minh City 211
Council Bluffs 192
Cambridge 170
The Dalles 149
Altamura 138
Ann Arbor 131
Chieti 130
Hanoi 129
Tongling 128
New York 117
Hong Kong 110
Buffalo 106
Nanchang 98
São Paulo 90
Boardman 81
Munich 81
Woodbridge 81
Moscow 78
Hebei 65
Shenyang 54
Houston 50
Kunming 49
Redondo Beach 45
Tianjin 44
Jiaxing 43
Helsinki 41
Tokyo 41
Washington 35
Hefei 33
Warsaw 33
Brussels 32
Grevenbroich 32
Montreal 31
Pescara 31
Brooklyn 30
Changsha 29
Milan 29
Denver 28
Hangzhou 28
San Francisco 28
San Mateo 28
Chennai 27
Poplar 27
Seattle 27
Stockholm 27
Atlanta 26
Riyadh 26
Norwalk 25
Orem 25
Toronto 25
Da Nang 24
Falls Church 24
Phoenix 24
Boston 23
Haiphong 23
Rio de Janeiro 23
Guangzhou 22
Jinan 22
Chicago 21
Augusta 20
Leawood 20
Nuremberg 20
Amsterdam 19
Johannesburg 19
Baghdad 18
Rome 18
Mexico City 17
Dhaka 16
London 16
Orange 16
Amman 15
Ankara 15
Frankfurt am Main 15
Manchester 15
Belo Horizonte 14
Biên Hòa 14
Dong Ket 14
Mumbai 14
Nairobi 14
Ningbo 14
Porto Alegre 14
Querétaro 14
Seoul 14
Taipei 14
Totale 13.676
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 830
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 318
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 242
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 173
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 172
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 169
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 167
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 160
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 156
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 155
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 154
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 152
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 147
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 146
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 145
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 144
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 142
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 141
Circulating leptin is associated with oxidized LDL in postmenopausal women. 141
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 139
Apixaban for extended treatment of venous thromboembolism 139
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 138
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 137
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 137
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 136
Oral rivaroxaban for symptomatic venous thromboembolism 136
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 134
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 134
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 133
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 132
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 132
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 132
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 131
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 131
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 130
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 129
[Physiopathological bases of the medical treatment of portal hypertension]. 129
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 129
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 128
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 127
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 127
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 127
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 126
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 125
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 125
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 125
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 125
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 125
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 125
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 125
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 125
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 123
Evidence for oxidative and not reductive stress in the aged rabbit heart 123
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 123
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients 123
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 122
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 122
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 121
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 121
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 121
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 121
Non-O blood group and outcomes of in vitro fertilization 121
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 120
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 120
Oral apixaban for the treatment of acute venous thromboembolism 120
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 120
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 120
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 119
Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients. 119
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 119
Altered doppler left ventricular (LV) diastolic function induced by handgrip in mild hypertensives with normal LV mass 119
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 119
18F-FDG PET-CT Imaging in Sarcoidosis Molecular Mechanisms and Applications 119
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 118
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 118
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 117
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 117
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 116
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 116
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 116
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 116
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 116
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 116
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 115
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 115
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 115
Determinants of platelet activation in Alzheimer's disease 115
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 114
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 114
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 114
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 112
Systemic oxidative stress status in patients with ischemic heart disease 112
Effects of body composition on the procoagulant imbalance in obese patients 112
Rivaroxaban for cancer-associated cardiac thrombosis 111
Iron status and oxidative stress in the aged rabbit heart 111
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 111
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 110
Inhibition of P-glycoprotein mediated transport by S-adenosylmethionine and Cynarin in multidrug resistant human uterine sarcoma MES-SA/Dx5 cells. 110
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 109
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 109
Totale 13.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20253.640 241 625 537 56 65 138 90 175 401 223 461 628
2025/20268.155 660 375 686 887 721 523 1.260 486 1.452 654 379 72
Totale 23.964